Chromatin Immunoprecipitation of Murine Brown Adipose Tissue
November 21st, 2018
7.9K views
Here we describe a protocol for efficient chromatin immunoprecipitation (ChIP) followed by high-throughput DNA sequencing (ChIP-seq) of brown adipose tissue (BAT) isolated from a mouse. This protocol is suitable for both mapping histone modifications and investigating genome-wide localization of non-histone proteins of interest in vivo.
Overview
This article describes a protocol for efficient chromatin immunoprecipitation (ChIP) followed by high-throughput DNA sequencing (ChIP-seq) of brown adipose tissue (BAT) isolated from mice. The method is optimized for immunoprecipitation of chromatin-associated complexes, enabling the study of histone modifications and non-histone proteins in vivo.
Key Study Components
Area of Science
- Neuroscience
- Genomics
- Cell Biology
Background
- Chromatin immunoprecipitation (ChIP) is a technique used to study protein-DNA interactions.
- High-throughput sequencing allows for genome-wide analysis of these interactions.
- Brown adipose tissue plays a crucial role in thermogenesis and energy metabolism.
- Understanding protein localization in BAT can provide insights into metabolic processes.
Purpose of Study
- To develop a reliable protocol for ChIP-seq in brown adipose tissue.
- To facilitate the mapping of histone modifications.
- To investigate the localization of non-histone proteins in vivo.
Methods Used
- Isolation of brown adipose tissue from euthanized mice.
- Cross-linking of BAT pads with formaldehyde.
- Immunoprecipitation of chromatin-associated complexes.
- High-throughput DNA sequencing for analysis.
Main Results
- The protocol successfully captures chromatin-associated proteins from BAT.
- Histone modifications were effectively mapped across the genome.
- Non-histone protein localization was analyzed in vivo.
- The method demonstrates high efficiency and reproducibility.
Conclusions
- This optimized ChIP-seq protocol is a valuable tool for studying BAT.
- It enhances our understanding of metabolic regulation in adipose tissue.
- The findings may have implications for obesity and metabolic disorders.
Frequently Asked Questions
What is the main advantage of this ChIP-seq protocol?
The protocol is optimized for efficient immunoprecipitation of chromatin-associated complexes from brown adipose tissue.
How is the brown adipose tissue prepared for analysis?
BAT is isolated from euthanized mice and cross-linked with formaldehyde before immunoprecipitation.
What types of proteins can be studied using this method?
Both histone modifications and non-histone proteins can be analyzed in vivo.
What are the implications of this research?
The findings may provide insights into metabolic regulation and potential treatments for metabolic disorders.
Is this protocol applicable to other tissues?
While this protocol is specifically designed for brown adipose tissue, similar methods can be adapted for other tissues.
What is the significance of studying brown adipose tissue?
BAT is important for thermogenesis and energy metabolism, making it a key area of research for obesity and metabolic health.
Executive Industry Relevance
Studying transcriptional regulation in physiologically relevant tissues like brown adipose tissue enables mechanistic de-risking of targets involved in metabolic pathways. This ChIP-seq protocol provides predictive confidence by mapping protein-DNA interactions in a disease-relevant system, supporting target validation and biomarker discovery in obesity and metabolic disorders. The approach enhances translational continuity from discovery to preclinical research by delivering quantitative, reproducible epigenomic data.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of transcriptional regulators like GPS2 in brown adipose tissue to validate targets controlling mitochondrial gene expression.
- Operational Value: Provides a reproducible method to assess transcription factor binding and histone modifications in primary tissue.
- Strategic Value: Supports target de-risking by confirming functional occupancy at promoters of nuclear-encoded mitochondrial genes.
Screening & Assay Development
- Scientific Value: Generates genome-wide binding profiles of histone marks and transcription factors for epigenetic screening campaigns.
- Operational Value: Delivers standardized ChIP-seq workflow with quantitative DNA recovery for assay consistency.
- Strategic Value: Facilitates assay readiness for screening compounds that modulate chromatin states in metabolic tissues.
Translational & Preclinical Research
- Scientific Value: Links chromatin states to metabolic phenotypes by analyzing H3K9ME3 and RNA polymerase II occupancy in BAT.
- Operational Value: Enables cross-genotype comparison (wildtype vs. knockout) to assess target modulation effects.
- Strategic Value: Supports preclinical validation of mechanistic hypotheses in a physiologically relevant adipose depot.
Pipeline & Workflow Integration
The method fits within the discovery biology to lead identification continuum by providing epigenomic readouts that inform target engagement and pathway modulation in metabolic disease models.
- Discovery Biology: Supports hypothesis testing of transcriptional regulators in brown adipose tissue through direct protein-DNA interaction mapping.
- Screening: Produces quantitative ChIP-seq data enabling comparison of compound effects on chromatin states in primary tissue.
- Analytics: Yields genome-wide localization data and quantitative PCR validation for assessing target engagement and epigenetic changes.
- Translational Research: Connects epigenetic modifications in BAT to mitochondrial function and thermogenesis, relevant to metabolic disease progression.
- Enterprise Reuse: Represents a adaptable ChIP-seq platform applicable across murine and human tissues for metabolic target validation.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through direct measurement of transcription factor binding and repressive histone marks in vivo.
- Operational Value: Standardized tissue processing and immunoprecipitation workflow ensuring reproducibility across laboratories.
- Strategic Value: Informs go/no-go decisions by reducing mechanistic ambiguity in transcriptional regulation of metabolic genes.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on chromatin occupancy and functional validation in disease-relevant tissue.
Implementation Considerations
- Requires expertise in chromatin biology, tissue handling, and next-generation sequencing library preparation.
- Needs instrumentation for tissue homogenization, sonication, immunoprecipitation, and high-throughput DNA sequencing.
- Demands cross-team standardization for tissue collection, cross-linking, and antibody validation to ensure data comparability.
- Involves adaptation considerations for different tissue types due to variability in chromatin accessibility and cellularity.
- Includes practical limitations such as hazardous reagent handling (phenol-chloroform) and input tissue yield from murine brown adipose tissue.
Biopharma FAQs
Why does GPS2 promoter occupancy matter for target validation in BAT?
GPS2 promoter occupancy was measured via ChIP-qPCR on nuclear-encoded mitochondrial genes NDUFV1 and TOMM20 in brown adipose tissue, showing decreased binding in GPS2-A knockout mice compared to wildtype littermates. This demonstrates target engagement and functional relevance of GPS2 in regulating mitochondrial gene expression in a physiologically relevant metabolic tissue.
How does isolating BAT under the skin between the shoulders support discovery pipeline goals?
Brown adipose tissue was carefully removed from under the skin between the shoulders after incision, ensuring isolation of the morphologically and physiologically distinct depot for analysis. This precise tissue isolation enables study of chromatin states in a thermogenically active fat depot relevant to energy metabolism and obesity research.
What quantitative dependent variable measurements enable mechanistic de-risking?
The protocol enables quantitative measurement of RNA polymerase II binding and H3K9ME3 histone mark levels via ChIP-qPCR, showing increased occupancy in GPS2-A knockout BAT versus wildtype. These measurements provide functional readouts of transcriptional repression and polymerase stalling, supporting mechanistic validation of GPS2’s role in preventing aberrant chromatin states.
Why do replication requirements matter for cross-functional collaboration in ChIP-seq?
The protocol includes parallel immunoprecipitation with pre-immune IgG or normal IgG controls and a no-antibody control to ensure specificity of chromatin pull-down. Replication with appropriate controls allows cross-functional teams to distinguish specific signal from background, ensuring data reliability for target validation and assay development.
What statistical analysis capabilities are required before implementing ChIP-seq in BAT?
Implementing this ChIP-seq protocol requires capability to analyze enrichment over input controls and compare immunoprecipitated DNA between genotypes using quantitative PCR or sequencing depth normalization. Statistical evaluation of fold-enrichment and significance (e.g., via t-test or ANOVA) is needed to validate differences in transcription factor binding or histone modification levels between experimental conditions.
